A novel anti-CD22 scFv–apoptin fusion protein induces apoptosis in malignant B-cells

CD22 marker is a highly internalizing antigen which is located on the surface of B-cells and is being used as a promising target for treatment of B cell malignancies. Monoclonal antibodies targeting CD22 have been introduced and some are currently under investigation in clinical trials. Building on...

Descripción completa

Detalles Bibliográficos
Autores principales: Agha Amiri, Solmaz, Shahhosseini, Soraya, Zarei, Najmeh, Khorasanizadeh, Dorsa, Aminollahi, Elahe, Rezaie, Faegheh, Zargari, Mehryar, Azizi, Mohammad, Khalaj, Vahid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5457376/
https://www.ncbi.nlm.nih.gov/pubmed/28582973
http://dx.doi.org/10.1186/s13568-017-0410-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5457376/
https://www.ncbi.nlm.nih.gov/pubmed/28582973
http://dx.doi.org/10.1186/s13568-017-0410-5

Ejemplares similares